These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 12616107)
1. Adjuvant immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with resected stage III and IV melanoma. Ridolfi L; Ridolfi R; Riccobon A; De Paola F; Petrini M; Stefanelli M; Flamini E; Ravaioli A; Verdecchia GM; Trevisan G; Amadori D J Immunother; 2003; 26(2):156-62. PubMed ID: 12616107 [TBL] [Abstract][Full Text] [Related]
2. [Adjuvant adoptive immunotherapy in patients with stage III and resected stage IV melanoma: a pilot study]. Verdecchia GM; Ridolfi L; Ridolfi R; Riccobon A; Bertagni A; Vagliasindi A; Petrini M; Stefanelli M; Milandri C; Amadori D Tumori; 2003; 89(4 Suppl):298-300. PubMed ID: 12903626 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant adoptive immunotherapy with tumour-infiltrating lymphocytes and modulated doses of interleukin-2 in 22 patients with melanoma, colorectal and renal cancer, after radical metastasectomy, and in 12 advanced patients. Ridolfi R; Flamini E; Riccobon A; De Paola F; Maltoni R; Gardini A; Ridolfi L; Medri L; Poletti G; Amadori D Cancer Immunol Immunother; 1998 Jun; 46(4):185-93. PubMed ID: 9671141 [TBL] [Abstract][Full Text] [Related]
4. Tumor infiltrating lymphocytes and continuous infusion interleukin-2 after metastasectomy in 61 patients with melanoma, colorectal and renal carcinoma. Fabbri M; Ridolfi R; Maltoni R; Ridolfi L; Riccobon A; Flamini E; De Paola F; Verdecchia GM; Amadori D Tumori; 2000; 86(1):46-52. PubMed ID: 10778766 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant, adoptive immunotherapy with tumor infiltrating lymphocytes plus interleukin-2 after radical hepatic resection for colorectal liver metastases: 5-year analysis. Gardini A; Ercolani G; Riccobon A; Ravaioli M; Ridolfi L; Flamini E; Ridolfi R; Grazi GL; Cavallari A; Amadori D J Surg Oncol; 2004 Jul; 87(1):46-52. PubMed ID: 15221919 [TBL] [Abstract][Full Text] [Related]
6. Tumor infiltrating lymphocytes as adjuvant treatment in stage III melanoma patients with only one invaded lymph node after complete resection: results from a multicentre, randomized clinical phase III trial. Khammari A; Nguyen JM; Leccia MT; Guillot B; Saiagh S; Pandolfino MC; Knol AC; Quéreux G; Chiffolettau A; Labarrière N; Dréno B Cancer Immunol Immunother; 2020 Aug; 69(8):1663-1672. PubMed ID: 32306076 [TBL] [Abstract][Full Text] [Related]
7. Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2. Nguyen LT; Saibil SD; Sotov V; Le MX; Khoja L; Ghazarian D; Bonilla L; Majeed H; Hogg D; Joshua AM; Crump M; Franke N; Spreafico A; Hansen A; Al-Habeeb A; Leong W; Easson A; Reedijk M; Goldstein DP; McCready D; Yasufuku K; Waddell T; Cypel M; Pierre A; Zhang B; Boross-Harmer S; Cipollone J; Nelles M; Scheid E; Fyrsta M; Lo CS; Nie J; Yam JY; Yen PH; Gray D; Motta V; Elford AR; DeLuca S; Wang L; Effendi S; Ellenchery R; Hirano N; Ohashi PS; Butler MO Cancer Immunol Immunother; 2019 May; 68(5):773-785. PubMed ID: 30747243 [TBL] [Abstract][Full Text] [Related]
8. Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study. Goedegebuure PS; Douville LM; Li H; Richmond GC; Schoof DD; Scavone M; Eberlein TJ J Clin Oncol; 1995 Aug; 13(8):1939-49. PubMed ID: 7636534 [TBL] [Abstract][Full Text] [Related]
9. Continuous interleukin-2 and tumor-infiltrating lymphocytes as treatment of advanced melanoma. A national biotherapy study group trial. Dillman RO; Oldham RK; Barth NM; Cohen RJ; Minor DR; Birch R; Yannelli JR; Maleckar JR; Sferruzza A; Arnold J Cancer; 1991 Jul; 68(1):1-8. PubMed ID: 2049729 [TBL] [Abstract][Full Text] [Related]
10. Infusion of in vitro expanded tumour-infiltrating lymphocytes and recombinant interleukin-2 in patients with surgically resected lymph node metastases of malignant melanoma: a pilot study. Reali UM; Martini L; Borgognoni L; Semino C; Pietra G; Chiarugi C; Guastella M; Melioli G Melanoma Res; 1998 Feb; 8(1):77-82. PubMed ID: 9508381 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis. Dafni U; Michielin O; Lluesma SM; Tsourti Z; Polydoropoulou V; Karlis D; Besser MJ; Haanen J; Svane IM; Ohashi PS; Kammula US; Orcurto A; Zimmermann S; Trueb L; Klebanoff CA; Lotze MT; Kandalaft LE; Coukos G Ann Oncol; 2019 Dec; 30(12):1902-1913. PubMed ID: 31566658 [TBL] [Abstract][Full Text] [Related]
12. Outcomes of Adoptive Cell Transfer With Tumor-infiltrating Lymphocytes for Metastatic Melanoma Patients With and Without Brain Metastases. Mehta GU; Malekzadeh P; Shelton T; White DE; Butman JA; Yang JC; Kammula US; Goff SL; Rosenberg SA; Sherry RM J Immunother; 2018 Jun; 41(5):241-247. PubMed ID: 29672342 [TBL] [Abstract][Full Text] [Related]
13. Adoptive immunotherapy with tumor-infiltrating lymphocytes and subcutaneous recombinant interleukin-2 plus interferon alfa-2a for melanoma patients with nonresectable distant disease: a phase I/II pilot trial. Melanoma Istituto Scientifico Tumori Group. Queirolo P; Ponte M; Gipponi M; Cafiero F; Peressini A; Semino C; Pietra G; Lionetto R; Vecchio S; Ribizzi I; Melioli G; Sertoli MR Ann Surg Oncol; 1999; 6(3):272-8. PubMed ID: 10340886 [TBL] [Abstract][Full Text] [Related]
14. Metastatic Lung Lesions as a Preferred Resection Site for Immunotherapy With Tumor Infiltrating Lymphocytes. Ben-Avi R; Itzhaki O; Simansky D; Zippel D; Markel G; Ben Nun A; Schachter J; Besser MJ J Immunother; 2016 Jun; 39(5):218-22. PubMed ID: 27163742 [TBL] [Abstract][Full Text] [Related]
15. Randomized trial of adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma. Dréno B; Nguyen JM; Khammari A; Pandolfino MC; Tessier MH; Bercegeay S; Cassidanius A; Lemarre P; Billaudel S; Labarrière N; Jotereau F Cancer Immunol Immunother; 2002 Nov; 51(10):539-46. PubMed ID: 12384805 [TBL] [Abstract][Full Text] [Related]
16. Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma. Alvarez-Downing MM; Inchauste SM; Dudley ME; White DE; Wunderlich JR; Rosenberg SA; Kammula US World J Surg Oncol; 2012 Jun; 10():113. PubMed ID: 22726267 [TBL] [Abstract][Full Text] [Related]